Eagle Pharmaceuticals, Inc. Financial Ratios — EGRX Stock

Profitability (USD)

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	09/30/2012	09/30/2013	09/30/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Return on Common Equity (%)	- -	- -	- -	4.17	67.44	31.45	18.77	8.42	6.57	-4.76	17.39
Return on Assets (%)	- -	-43.92	-50.28	2.89	48.07	21.45	12.54	5.8	4.72	-3.4	10.8
Return on Capital (%)	- -	- -	- -	4.18	- -	27.9	15.95	7.54	6.06	- -	15.08
Return on Invested Capital (%)	- -	- -	- -	4.14	- -	28.43	20.16	6.67	7.9	- -	18.46
Gross Margin (%)	-24.69	46.04	38.67	76.37	70.81	75.84	70.97	68.91	75.79	75.41	70.01
EBITDA Margin (%)	-771.6	-60.82	-97.66	4.03	28.58	33.48	23.5	12.92	19.43	3.81	29.37
Operating Margin (%)	-781.06	-61.81	-98.21	3.87	27.74	31.9	21.78	11.14	17.55	1.61	25.57
Incremental Operating Margin (%)	- -	- -	- -	45.23	40.56	48.58	124.09	141.52	-137.69	185.69	53.9
Pretax Margin (%)	-794.17	-50.79	-100.91	3.89	28.2	30.82	15.96	11.23	12.07	-2.65	19.4
Profit Margin (%)	-763.41	-44.21	-94.13	3.88	42.99	21.94	14.96	7.31	6.38	-5.03	11.26
Net Income to Common Margin (%)	-918.31	-72.26	-102.85	3.88	42.99	21.94	14.96	7.31	6.38	-5.03	11.26
Effective Tax Rate (%)	- -	- -	- -	0.12	- -	28.79	6.27	34.93	47.13	- -	41.98
Dvd Payout Ratio (%)	16.87	38.82	8.48	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	4.17	67.44	31.45	18.77	8.42	6.57	-4.76	17.39

Credit (USD)

Credit Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	09/30/2012	09/30/2013	09/30/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Total Debt	9	- -	- -	- -	- -	48	44	42	34	30	64
ST Debt	9	- -	- -	- -	- -	5	6	5	9	27	8
LT Debt	- -	- -	- -	- -	- -	43	38	37	25	3	56
Total Debt/EBITDA	-0.44	- -	- -	- -	- -	0.6	0.89	1.64	0.94	4.57	0.69
Net Debt/EBITDA	-0.18	1.26	1.22	-29.6	-0.98	-0.84	-0.69	-2.81	-1.92	-11.04	0.08
Total Debt/EBIT	-0.43	- -	- -	- -	- -	0.63	0.96	1.9	1.04	10.77	0.79
Net Debt/EBIT	-0.18	1.24	1.21	-30.89	-1	-0.89	-0.74	-3.26	-2.12	-26.02	0.09
EBITDA to Interest Expense	-63.4	-5.94	-2,331.62	242.91	6,768.38	69.76	18.33	9.42	14.16	3.99	22.99
EBITDA-CapEx/Interest Expense	-63.51	-5.97	-2,337.38	71.91	4,182.12	65.19	18.28	9.13	13.87	3.8	22.94
EBIT to Interest Expense	-64.18	-6.04	-2,344.62	232.73	6,569.75	66.46	16.98	8.12	12.79	1.69	20.01
Interest Expense	- -	1	- -	- -	- -	1	3	3	3	2	4
Common Equity/Total Assets	-989.97	-485.72	61.96	72.5	70.56	66.33	67.38	70.39	73.47	69.54	57.5
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	23.95	23.73	20.4	13.51	1.65	24.07
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	18.91	18.6	16.56	11.41	1.41	18.89
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	15.89	15.99	14.36	9.93	1.14	13.84
Total Debt/Equity (%)	-70.85	- -	- -	- -	- -	26.67	27.62	23.19	18.42	16.9	27.4
Total Debt/Capital (%)	-243.09	- -	- -	- -	- -	21.06	21.64	18.83	15.55	14.46	21.51
Total Debt/Total Assets (%)	90.82	- -	- -	- -	- -	17.69	18.61	16.33	13.53	11.75	15.76
Net Debt to Equity	-28.97	-509.06	-68.65	-87.54	-34.93	-37.33	-21.39	-39.75	-37.64	-40.83	3.06
Net Debt/Capital (%)	-40.79	124.45	-219.03	-702.34	-53.68	-59.57	-27.21	-64.19	-59.79	-66.34	2.95
EBITDA	-20	-8	-19	3	54	79	50	25	36	7	93
EBITDA-CapEx	-20	-8	-19	1	33	74	50	25	36	6	93
Operating Income (Loss)	-20	-8	-19	3	53	75	46	22	33	3	81

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	09/30/2012	09/30/2013	09/30/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Cash Ratio	0.31	0.73	2.1	2.31	1.29	2.42	1.99	2.83	2.71	1.31	0.5
Current Ratio	0.42	1.22	2.61	3.57	2.66	3.99	4.13	4.62	4.36	2.32	1.7
Quick Ratio	0.39	1.09	2.46	3.07	2.32	3.56	3.66	4.06	4.05	1.94	1.16
CFO/Avg Current Liab	- -	-0.33	-0.8	-0.36	1.41	1.34	1.2	1.43	1.29	0.5	0.55
Common Equity/Total Assets	-989.97	-485.72	61.96	72.5	70.56	66.33	67.38	70.39	73.47	69.54	57.5
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	23.95	23.73	20.4	13.51	1.65	24.07
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	18.91	18.6	16.56	11.41	1.41	18.89
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	15.89	15.99	14.36	9.93	1.14	13.84
Total Debt/Equity (%)	-70.85	- -	- -	- -	- -	26.67	27.62	23.19	18.42	16.9	27.4
Total Debt/Capital (%)	-243.09	- -	- -	- -	- -	21.06	21.64	18.83	15.55	14.46	21.51
Total Debt/Total Assets (%)	90.82	- -	- -	- -	- -	17.69	18.61	16.33	13.53	11.75	15.76
CFO/Total Liabilities	-72.2	-36.63	-68.14	-28.36	84.33	64.81	67.3	74.27	73.68	36.52	29.37
CFO/CapEx	-471.15	-143.39	-300.93	-5.17	2.57	11.36	393.86	72.05	66.26	87.37	284.84
Altman's Z-Score	-22.36	-8.48	2.45	24.52	14.46	8.58	7.62	9.22	8.27	7.05	4.75

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	09/30/2012	09/30/2013	09/30/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Accounts Receivable Turnover	- -	4.08	3.08	3.95	5.54	4.93	3.55	3.42	3.79	3.72	5.57
Days Sales Outstanding	- -	89.45	118.68	92.49	65.94	74.03	102.93	106.66	96.32	98.16	65.47
Inventory Turnover	- -	169.91	18.11	1.92	6.22	14.56	9.23	8.19	6.21	2.81	2.72
Days Inventory Outstanding	- -	2.15	20.16	190.54	58.67	25.07	39.56	44.56	58.77	129.73	133.99
Accounts Payable Turnover	- -	5.53	4.95	7.43	4.63	4.46	5.95	7.69	8.01	4.94	6.82
Accounts Payable Turnover Days	- -	65.95	73.67	49.15	78.82	81.8	61.39	47.44	45.57	73.96	53.51
Cash Conversion Cycle	- -	25.65	65.17	233.88	45.79	17.31	81.1	103.78	109.52	153.93	145.96
Inventory to Cash Days	- -	87.31	98.52	-98.05	7.26	48.95	63.37	62.1	37.55	-31.57	-68.52
Inventories	- -	- -	1	15	3	5	8	7	8	22	48
Raw Materials	- -	- -	- -	9	1	2	6	2	4	7	12
Work In Process	- -	- -	- -	6	1	1	2	3	3	10	14
Finished Goods	- -	- -	1	- -	1	2	- -	1	2	5	21
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	09/30/2012	09/30/2013	09/30/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Market Capitalization	- -	- -	178	1,386	1,216	793	561	819	608	651	380
- Cash & Cash Equivalents	5	10	23	79	53	115	79	110	103	98	55
+ Preferred Equity and Hybrid Capital	81	90	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	9	- -	- -	- -	- -	48	44	42	34	30	64
Enterprise Value	83	80	135	1,307	1,163	726	526	751	539	583	389
Total Capital	-4	2	33	90	151	227	205	221	220	206	298
Total Debt/Capital (%)	-243.09	- -	- -	- -	- -	21.06	21.64	18.83	15.55	14.46	21.51
Total Debt / EV	0.1	- -	- -	- -	- -	0.07	0.08	0.06	0.06	0.05	0.16
EV/Sales	32.82	5.81	7.06	19.74	6.14	3.07	2.47	3.83	2.87	3.4	1.23
EV/EBITDA	- -	- -	- -	489.29	21.48	9.17	10.5	29.66	14.77	89.37	4.19
EV/EBIT	- -	- -	- -	510.7	22.13	9.62	11.32	34.41	16.36	210.73	4.81
EV/Cash Flow to Firm	- -	- -	- -	- -	21.85	12.16	9.58	13	10.6	18.63	7.34
EV/Free Cash Flow to Firm	- -	- -	- -	- -	15.74	11.19	9.55	12.83	10.45	18.44	7.31
Diluted Market Cap	- -	- -	126	1,441	1,304	850	616	849	641	665	382
Diluted Enterprise Value	85	80	103	1,362	1,251	783	581	781	572	597	391
EV per Share	5.99	5.71	9.61	83.61	75.89	48.92	37.82	55.08	41.29	45.62	29.9
TTM Sales	3	14	19	66	189	237	213	196	188	172	317
TTM EBITDA	-20	-8	-19	3	54	79	50	25	36	7	93
TTM Operating Income	-20	-8	-19	3	53	75	46	22	33	3	81
TTM Cash Flow to Firm	-15	-5	-14	-10	53	60	55	58	51	31	53
TTM Free Cash Flow to Firm	-15	-5	-14	-8	74	65	55	59	52	32	53

Multiples (USD)

Valuation Multiples API ChatGPT

	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
As of date	09/30/2012	09/30/2013	09/30/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022

Price/Free Cash Flow	- -	- -	-9.13	-183.9	17.64	13.26	11.72	14.96	12.76	23.28	7.51
EV/EBIT	- -	- -	- -	510.7	22.13	9.62	11.32	34.41	16.36	210.73	4.81
Enterprise Value	83	80	135	1,307	1,163	726	526	751	539	583	389
Low Price	- -	- -	9.16	14.89	33.02	45.05	36.03	38.38	33.8	36.48	24.35
EV/Sales	32.82	5.81	7.06	19.74	6.14	3.07	2.47	3.83	2.87	3.4	1.23
EV/EBITDA	- -	- -	- -	489.29	21.48	9.17	10.5	29.66	14.77	89.37	4.19
Price/Earnings	- -	- -	- -	525.96	15.13	15.53	18.65	57.74	52.37	- -	10.61
Price/Earnings Average	- -	- -	-6.21	381.6	11.09	19.78	28.76	51.16	53.55	-71.42	14.71
Price/Earnings High	- -	- -	-8.33	617.9	16.87	28.25	39.65	62.41	68.22	-88.12	19.52
Price/Earnings Low	- -	- -	-4.64	88.32	6.3	13.1	16.68	36.88	38.01	-55.19	8.84
Price/Book Value	- -	- -	5.36	15.35	8.04	4.43	3.49	4.57	3.27	3.69	1.63
Price/Book Value Average	- -	- -	5.19	11.13	5.89	5.64	5.38	4.05	3.34	3.42	2.26
Price/Book Value High	- -	- -	6.97	18.03	8.96	8.05	7.41	4.94	4.26	4.22	3
Price/Book Value Low	- -	- -	3.88	2.58	3.35	3.73	3.12	2.92	2.37	2.64	1.36
Price/Tangible Book Value	- -	- -	5.36	15.35	15.57	6.83	5.45	6.61	4.56	5.17	5.42
Price/Tangible Book Value Average	- -	- -	5.19	11.13	11.41	8.7	8.4	5.86	4.66	4.79	7.52
Price/Tangible Book Value High	- -	- -	6.97	18.03	17.36	12.43	11.58	7.15	5.94	5.91	9.97
Price/Tangible Book Value Low	- -	- -	3.88	2.58	6.48	5.76	4.87	4.22	3.31	3.7	4.52
Price/Sales	- -	- -	6.59	20.42	6.5	3.41	2.79	4.22	3.34	3.87	1.19
Price/Sales Average	- -	- -	6.39	14.81	4.77	4.34	4.3	3.74	3.42	3.59	1.66
Price/Sales High	- -	- -	8.57	23.99	7.25	6.2	5.93	4.56	4.35	4.43	2.2
Price/Sales Low	- -	- -	4.77	3.43	2.71	2.87	2.49	2.69	2.43	2.78	0.99
Price/Cash Flow	- -	- -	-9.1	-139.15	23.16	13.69	11.36	14.76	12.68	23.55	7.46
Price/Cash Flow Average	- -	- -	-8.81	-100.96	16.98	17.44	17.52	13.08	12.97	21.83	10.34
Price/Cash Flow High	- -	- -	-11.82	-163.47	25.83	24.9	24.15	15.95	16.52	26.94	13.72
Price/Cash Flow Low	- -	- -	-6.59	-23.37	9.64	11.55	10.16	9.43	9.21	16.87	6.21
Price/Free Cash Flow Average	- -	- -	-8.84	-133.43	12.94	16.89	18.08	13.26	13.05	21.59	10.41
Price/Free Cash Flow High	- -	- -	-11.86	-216.05	19.68	24.11	24.92	16.18	16.63	26.64	13.81
Price/Free Cash Flow Low	- -	- -	-6.61	-30.88	7.34	11.18	10.48	9.56	9.26	16.68	6.25
EV/Sales Average	33.42	5.81	7.81	14	4.43	3.99	3.89	3.36	2.94	3.12	1.69
EV/Sales High	33.42	5.81	10.89	23.4	6.88	5.81	5.43	4.17	3.85	3.95	2.24
EV/Sales Low	33.42	5.81	5.54	2.32	2.39	2.54	2.19	2.32	1.98	2.32	1.03
EV/EBITDA Average	-4.33	-9.56	-8	346.88	15.49	11.9	16.56	25.98	15.15	82.1	5.77
EV/EBITDA High	-4.33	-9.56	-11.15	580	24.06	17.36	23.09	32.28	19.82	103.73	7.62
EV/EBITDA Low	-4.33	-9.56	-5.67	57.54	8.37	7.6	9.31	17.98	10.21	61.08	3.5
EV/EBIT Average	-4.28	-9.41	-7.95	362.06	15.95	12.5	17.87	30.14	16.78	193.59	6.62
EV/EBIT High	-4.28	-9.41	-11.09	605.37	24.79	18.22	24.91	37.45	21.95	244.59	8.75
EV/EBIT Low	-4.28	-9.41	-5.64	60.06	8.62	7.97	10.05	20.85	11.3	144.02	4.02
Last Price	- -	- -	12.65	88.67	79.34	53.42	40.29	60.08	46.57	50.92	29.23
High Price	- -	- -	16.44	104.17	88.47	97.15	85.66	64.94	60.66	58.25	53.78
Enterprise Value Average	85	80	149	927	839	943	830	657	553	536	536
Enterprise Value High	85	80	208	1,550	1,303	1,376	1,157	817	723	677	709
Enterprise Value Low	85	80	106	154	453	602	467	455	372	399	326

Shares Outstanding	14	14	14	16	15	15	14	14	13	13	13
Diluted Weighted Avg Shares	11	11	10	16	16	16	15	14	14	13	13
Basic Weighted Avg Shares	11	11	10	15	16	15	15	14	13	13	13
Revenue per Share	0.24	1.29	1.92	4.34	12.2	15.67	14.44	14.24	13.93	13.14	24.48
EBITDA per Share	-1.85	-0.79	-1.87	0.18	3.49	5.25	3.39	1.84	2.71	0.5	7.19
Operating Income per Share	-1.88	-0.8	-1.88	0.17	3.38	5	3.15	1.59	2.44	0.21	6.26
Basic EPS, GAAP	-2.21	-0.94	-1.97	0.17	5.24	3.44	2.16	1.04	0.89	-0.66	2.76
Basic EPS from Cont Ops	-1.83	-0.57	-1.81	0.17	5.24	3.44	2.16	1.04	0.89	-0.66	2.76
Diluted EPS, GAAP	-2.21	-0.94	-1.97	0.16	4.96	3.27	2.09	1.01	0.87	-0.66	2.73
Diluted EPS from Cont Ops	-1.83	-0.57	-1.81	0.16	4.96	3.27	2.09	1.01	0.87	-0.66	2.73
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.47	-0.56	-1.39	-0.64	3.43	3.9	3.55	4.07	3.67	2.16	3.92
Free Cash Flow per Basic Share	-1.47	-0.56	-1.4	-0.76	2.09	3.56	3.54	4.01	3.62	2.14	3.91
Cash & Equivalents per Share	0.47	0.75	3.04	5.06	3.45	7.72	5.66	8.05	7.9	7.63	4.25
Book Value per Share	-6.71	-6.32	2.36	5.78	9.87	12.07	11.55	13.15	14.25	13.79	17.94
Tangible Book Value per Share	-6.71	-6.32	2.36	5.78	5.1	7.82	7.4	9.09	10.21	9.85	5.39

Eagle Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)